...
首页> 外文期刊>European review for medical and pharmacological sciences. >Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients
【24h】

Credibility of the measurement of serum ferritin and transferrin receptor as indicators of iron deficiency anemia in hemodialysis patients

机译:血清铁蛋白和转铁蛋白受体测定作为血液透析患者缺铁性贫血指标的可信度

获取原文
           

摘要

Background and Objectives: Anemia is a common complication in uremic patients. Erythropoietin therapy is prescribed in these cases; however, this treatment is not successful in iron deficient patients. Ferritin-based diagnosis of iron deficiency in these patients is a challenging task, as serum ferritin level may be high due to chronic inflammation and mask iron deficiency. In the current study we evaluated the credibility of another indicator of body iron supply, serum transferrin receptor, in hemodialysis patients in two University-based Hospitals in North of Iran. Materials and Methods: In a cross-sectional study, 53 hemodialysis patients with a mean age of 56 ± 18.7 years and 30 persons with iron deficiency and normal renal function with a mean age of 20.1 ± 14.4 years were examined. All hemodialysis patients were on hemodialysis 2-3 times per week for 3-4 hours. All cases were examined for blood hemoglobin content, serum iron, CRP, serum ferritin and serum transferrin receptor levels. The reference ranges introduced by manufacturers were considered as standard ranges for analysis of the results. Using one sample T-test and Fisher’s exact test, data were analyzed. p < 0.05 was considered as significant. Results: Hemodialysis patients had blood hemoglobin content below normal range (p < 0.05 for men, p < 0.001 for women) and CRP levels above normal range (p < 0.001). In hemodialysis patients, serum ferritin level was significantly higher than control group (p < 0.001), whilst serum transferrin receptor levels in the two groups were not significantly different (p = 0.69), and both were above defined normal upper limit (p < 0.001 for iron deficient patients; p < 0.05 for hemodialysis patients). Discussion: This study showed measurement of serum ferritin in the presence of chronic inflammation induced by renal failure cannot be a credible indicator of body iron supply, while under this certain condition serum transferrin receptor can more appropriately reflect the amount of body iron supply. Corresponding Author: Atieh Makhlough, MD; e-mail: makhlough_a@yahoo.com
机译:背景与目的:贫血是尿毒症患者的常见并发症。在这些情况下,应使用促红细胞生成素疗法。但是,这种治疗在铁缺乏症患者中并不成功。在这些患者中,基于铁蛋白的铁缺乏症诊断是一项艰巨的任务,因为由于慢性炎症和面膜铁缺乏症,血清铁蛋白水平可能很高。在本研究中,我们评估了伊朗北部两家大学医院的血液透析患者体内铁供应的另一指标血清转铁蛋白受体的可信度。材料和方法:在一项横断面研究中,检查了53名平均年龄为56±18.7岁的血液透析患者和30名铁缺乏且肾功能正常的人,平均年龄为20.1±14.4岁。所有血液透析患者每周接受2-3次血液透析,持续3-4小时。检查所有病例的血红蛋白含量,血清铁,CRP,血清铁蛋白和血清转铁蛋白受体水平。制造商介绍的参考范围被认为是分析结果的标准范围。使用一个样本T检验和Fisher精确检验,对数据进行了分析。 p <0.05被认为是显着的。结果:血液透析患者的血红蛋白含量低于正常范围(男性为p <0.05,女性为p <0.001),CRP水平高于正常范围(p <0.001)。在血液透析患者中​​,血清铁蛋白水平显着高于对照组(p <0.001),而两组的血清转铁蛋白受体水平无显着差异(p = 0.69),且均高于正常上限(p <0.001)对于铁缺乏的患者;对于血液透析患者,p <0.05)。讨论:这项研究表明,在肾功能衰竭导致的慢性炎症存在下,血清铁蛋白的测定不能作为人体铁供应的可靠指标,而在这种情况下,血清转铁蛋白受体可以更恰当地反映人体铁的供应量。通讯作者:医学博士Atieh Makhlough;电子邮件:makhlough_a@yahoo.com

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号